Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mirum Pharmaceuticals (MIRM) Goodwill & Intangibles: 2021-2024

Historic Goodwill & Intangibles for Mirum Pharmaceuticals (MIRM) over the last 4 years, with Dec 2024 value amounting to $249.8 million.

  • Mirum Pharmaceuticals' Goodwill & Intangibles fell 9.34% to $231.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $231.9 million, marking a year-over-year decrease of 9.34%. This contributed to the annual value of $249.8 million for FY2024, which is 1.23% down from last year.
  • Latest data reveals that Mirum Pharmaceuticals reported Goodwill & Intangibles of $249.8 million as of FY2024, which was down 1.23% from $252.9 million recorded in FY2023.
  • In the past 5 years, Mirum Pharmaceuticals' Goodwill & Intangibles ranged from a high of $252.9 million in FY2023 and a low of $18.7 million during FY2021.
  • Moreover, its 3-year median value for Goodwill & Intangibles was $249.8 million (2024), whereas its average is $187.2 million.
  • As far as peak fluctuations go, Mirum Pharmaceuticals' Goodwill & Intangibles spiked by 329.02% in 2023, and later declined by 1.23% in 2024.
  • Mirum Pharmaceuticals' Goodwill & Intangibles (Yearly) stood at $18.7 million in 2021, then soared by 214.59% to $59.0 million in 2022, then spiked by 329.02% to $252.9 million in 2023, then dropped by 1.23% to $249.8 million in 2024.